Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies
Authors: Denise M. Wolf | Christina Yau | Julia Wulfkuhle | Lamorna Brown-Swigart | Rosa I. Gallagher | Pei Rong Evelyn Lee | Zelos Zhu | Mark J. Magbanua | Rosalyn Sayaman | Nicholas O’Grady | Amrita Basu | Amy Delson | Jean Philippe Coppé | Ruixiao Lu | Jerome Braun | Smita M. Asare | Laura Sit | Jeffrey B. Matthews | Jane Perlmutter | Nola Hylton | Minetta C. Liu | Paula Pohlmann | W. Fraser Symmans | Hope S. Rugo | Claudine Isaacs | Angela M. DeMichele | Douglas Yee | Donald A. Berry | Lajos Pusztai | Emanuel F. Petricoin | Gillian L. Hirst | Laura J. Esserman | Laura J. van 't Veer
|
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial
Authors: Lajos Pusztai | Christina Yau | Denise M. Wolf | Hyo S. Han | Lili Du | Anne M. Wallace | Erica String-Reasor | Judy C. Boughey | A. Jo Chien | Anthony D. Elias | Heather Beckwith | Rita Nanda | Kathy S. Albain | Amy S. Clark | Kathleen Kemmer | Kevin Kalinsky | Claudine Isaacs | Alexandra Thomas | Rebecca Shatsky | Theresa L. Helsten | Andres Forero-Torres | Minetta C. Liu | Lamorna Brown-Swigart | Emmanuel F. Petricoin | Julia D. Wulfkuhle | Smita M. Asare | Amy Wilson | Ruby Singhrao | Laura Sit | Gillian L. Hirst | Scott Berry | Ashish Sanil | Adam L. Asare | Jeffrey B. Matthews | Jane Perlmutter | Michelle Melisko | Hope S. Rugo | Richard B. Schwab | W. Fraser Symmans | Doug Yee | Laura J. van’t Veer | Nola M. Hylton | Angela M. DeMichele | Donald A. Berry | Laura J. Esserman
|
COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer
Authors: Cong Zeng | John P. Evans | Karthik Chakravarthy | Panke Qu | Sarah Reisinger | No-Joon Song | Mark P. Rubinstein | Peter G. Shields | Zihai Li | Shan-Lu Liu
|
STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcoma
Authors: Biniam Adane | Gabriela Alexe | Bo Kyung A. Seong | Diana Lu | Elizabeth E. Hwang | Denes Hnisz | Caleb A. Lareau | Linda Ross | Shan Lin | Filemon S. Dela Cruz | Melissa Richardson | Abraham S. Weintraub | Sarah Wang | Amanda Balboni Iniguez | Neekesh V. Dharia | Amy Saur Conway | Amanda L. Robichaud | Benjamin Tanenbaum | John M. Krill-Burger | Francisca Vazquez | Monica Schenone | Jason N. Berman | Andrew L. Kung | Steven A. Carr | Martin J. Aryee | Richard A. Young | Brian D. Crompton | Kimberly Stegmaier
|
Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes
Authors: Pascal D. Johann | Serap Erkek | Marc Zapatka | Kornelius Kerl | Ivo Buchhalter | Volker Hovestadt | David T.W. Jones | Dominik Sturm | Carl Hermann | Maia Segura Wang | Andrey Korshunov | Marina Rhyzova | Susanne Gröbner | Sebastian Brabetz | Lukas Chavez | Susanne Bens | Stefan Gröschel | Fabian Kratochwil | Andrea Wittmann | Laura Sieber | Christina Geörg | Stefan Wolf | Katja Beck | Florian Oyen | David Capper | Peter van Sluis | Richard Volckmann | Jan Koster | Rogier Versteeg | Andreas von Deimling | Till Milde | Olaf Witt | Andreas E. Kulozik | Martin Ebinger | Tarek Shalaby | Michael Grotzer | David Sumerauer | Josef Zamecnik | Jaume Mora | Nada Jabado | Michael D. Taylor | Annie Huang | Eleonora Aronica | Anna Bertoni | Bernhard Radlwimmer | Torsten Pietsch | Ulrich Schüller | Reinhard Schneppenheim | Paul A. Northcott | Jan O. Korbel | Reiner Siebert | Michael C. Frühwald | Peter Lichter | Roland Eils | Amar Gajjar | Martin Hasselblatt | Stefan M. Pfister | Marcel Kool
|
New Views into the Genetic Landscape of Metastatic Breast Cancer
Authors: Xiaoyu Zhao | Scott Powers
|
The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia
Authors: Mingyang Liu | Yu Ren | Zhijun Zhou | Jingxuan Yang | Xiuhui Shi | Yang Cai | Alex X. Arreola | Wenyi Luo | Kar-Ming Fung | Chao Xu | Ryan D. Nipp | Michael S. Bronze | Lei Zheng | Yi-Ping Li | Courtney W. Houchen | Yuqing Zhang | Min Li
|
Myosin II Reactivation and Cytoskeletal Remodeling as a Hallmark and a Vulnerability in Melanoma Therapy Resistance
Authors: Jose L. Orgaz | Eva Crosas-Molist | Amine Sadok | Anna Perdrix-Rosell | Oscar Maiques | Irene Rodriguez-Hernandez | Jo Monger | Silvia Mele | Mirella Georgouli | Victoria Bridgeman | Panagiotis Karagiannis | Rebecca Lee | Pahini Pandya | Lena Boehme | Fredrik Wallberg | Chris Tape | Sophia N. Karagiannis | Ilaria Malanchi | Victoria Sanz-Moreno
|
Synergy between PPARγ Ligands and Platinum-Based Drugs in Cancer
Authors: Geoffrey D. Girnun | Elnaz Naseri | Scott B. Vafai | Lishu Qu | Jeffrey D. Szwaya | Roderick Bronson | John A. Alberta | Bruce M. Spiegelman
|
Undifferentiated Sarcomas Develop through Distinct Evolutionary Pathways
Authors: Christopher D. Steele | Maxime Tarabichi | Dahmane Oukrif | Amy P. Webster | Hongtao Ye | Matthew Fittall | Patrick Lombard | Iñigo Martincorena | Patrick S. Tarpey | Grace Collord | Kerstin Haase | Sandra J. Strauss | Fitim Berisha | Heli Vaikkinen | Pawan Dhami | Marnix Jansen | Sam Behjati | M. Fernanda Amary | Roberto Tirabosco | Andrew Feber | Peter J. Campbell | Ludmil B. Alexandrov | Peter Van Loo | Adrienne M. Flanagan | Nischalan Pillay
|
Therapeutic Targeting of CDK12/CDK13 in Triple-Negative Breast Cancer
Authors: Victor Quereda | Simon Bayle | Francesca Vena | Sylvia M. Frydman | Andrii Monastyrskyi | William R. Roush | Derek R. Duckett
|
A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor
Authors: Kimita Suyama | Irina Shapiro | Mitchell Guttman | Rachel B. Hazan
|
A Murine Model of Chronic Lymphocytic Leukemia Based on B Cell-Restricted Expression of Sf3b1 Mutation and Atm Deletion
Authors: Shanye Yin | Rutendo G. Gambe | Jing Sun | Aina Zurita Martinez | Zachary J. Cartun | Fara Faye D. Regis | Youzhong Wan | Jean Fan | Angela N. Brooks | Sarah E.M. Herman | Elisa ten Hacken | Amaro Taylor-Weiner | Laura Z. Rassenti | Emanuela M. Ghia | Thomas J. Kipps | Esther A. Obeng | Carrie L. Cibulskis | Donna Neuberg | Dean R. Campagna | Mark D. Fleming | Benjamin L. Ebert | Adrian Wiestner | Ignaty Leshchiner | James A. DeCaprio | Gad Getz | Robin Reed | Ruben D. Carrasco | Catherine J. Wu | Lili Wang
|
BRAF Mutants Evade ERK-Dependent Feedback by Different Mechanisms that Determine Their Sensitivity to Pharmacologic Inhibition
Authors: Zhan Yao | Neilawattie M. Torres | Anthony Tao | Yijun Gao | Lusong Luo | Qi Li | Elisa de Stanchina | Omar Abdel-Wahab | David B. Solit | Poulikos I. Poulikakos | Neal Rosen
|
Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants
Authors: Bryan D. Smith | Michael D. Kaufman | Wei-Ping Lu | Anu Gupta | Cynthia B. Leary | Scott C. Wise | Thomas J. Rutkoski | Yu Mi Ahn | Gada Al-Ani | Stacie L. Bulfer | Timothy M. Caldwell | Lawrence Chun | Carol L. Ensinger | Molly M. Hood | Arin McKinley | William C. Patt | Rodrigo Ruiz-Soto | Ying Su | Hanumaiah Telikepalli | Ajia Town | Benjamin A. Turner | Lakshminarayana Vogeti | Subha Vogeti | Karen Yates | Filip Janku | Albiruni Ryan Abdul Razak | Oliver Rosen | Michael C. Heinrich | Daniel L. Flynn
|
Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2
Authors: Scott A. Foster | Daniel M. Whalen | Ayşegül Özen | Matthew J. Wongchenko | JianPing Yin | Ivana Yen | Gabriele Schaefer | John D. Mayfield | Juliann Chmielecki | Philip J. Stephens | Lee A. Albacker | Yibing Yan | Kyung Song | Georgia Hatzivassiliou | Charles Eigenbrot | Christine Yu | Andrey S. Shaw | Gerard Manning | Nicholas J. Skelton | Sarah G. Hymowitz | Shiva Malek
|
CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitors
Authors: Sadhna R. Vora | Dejan Juric | Nayoon Kim | Mari Mino-Kenudson | Tiffany Huynh | Carlotta Costa | Elizabeth L. Lockerman | Sarah F. Pollack | Manway Liu | Xiaoyan Li | Joseph Lehar | Marion Wiesmann | Markus Wartmann | Yan Chen | Z. Alexander Cao | Maria Pinzon-Ortiz | Sunkyu Kim | Robert Schlegel | Alan Huang | Jeffrey A. Engelman
|
Inflammation, ROS, and Mutagenesis
Authors: Asmaa El-Kenawi | Brian Ruffell
|
Structural Decoding of the Netrin-1/UNC5 Interaction and its Therapeutical Implications in Cancers
Authors: Mélodie Grandin | Markus Meier | Jean Guy Delcros | Denise Nikodemus | Raphael Reuten | Trushar R. Patel | David Goldschneider | George Orriss | Natalie Krahn | Amina Boussouar | Riad Abes | Yann Dean | David Neves | Agnes Bernet | Stephane Depil | Fiona Schneiders | Kate Poole | Robert Dante | Manuel Koch | Patrick Mehlen | Jörg Stetefeld
|
Response to Harper et al.
Authors: Dagmar Schumacher | Boris Strilic | Kishor Kumar Sivaraj | Nina Wettschureck | Stefan Offermanns
|